Aveanna upgraded to Buy from Hold at Jefferies

Jefferies upgraded Aveanna (AVAH) to Buy from Hold with a price target of $6, down from $6.25, ahead of the Q2 report. The firm expects fundamental strength and positive earnings surprises from Aveanna due to its focus on bolstering capacity and better reimbursing payer contracts. The share selloff on the home nursing rate proposal is overdone since Medicare home health is a smaller portion of Aveanna’s business, the analyst tells investors in a research note.